Extract from the Register of European Patents

EP Citations: EP3124015

Cited inSearch
Type:Patent literature
Publication No.:EP2228058  [A]
 (NOVAGALI PHARMA SA [FR]) [A] 1-16 * paragraph [0005] * * page 3, line 17 * * page 3, line 20 - line 22 * * page 3, line 33 - line 34 * * paragraph [0020] *;
Type:Non-patent literature
Publication information:[A]  - HEE YOUNG CHOI ET AL, "In Vitro Study of Antiadipogenic Profile of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in Human Orbital Preadiopocytes", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS., US, (201204), vol. 28, no. 2, doi:10.1089/jop.2011.0160, ISSN 1080-7683, pages 146 - 152, XP055131156 [A] 1-16 * the whole document *
DOI: http://dx.doi.org/10.1089/jop.2011.0160
Cited inby applicant
Type:Patent literature
Publication No.:US2010234466  
Type:Patent literature
Publication No.:WO2012099942  
Type:Patent literature
Publication No.:US8426471  
Type:Non-patent literature
Publication information:   - "Delivery System Design in Topically Applied Formulations: An Overview", DAYAN N, Delivery System Handbook for Personal Care and Cosmetic Products, WILLIAM ANDREW, (2005), pages 103 - 104
Type:Non-patent literature
Publication information:   - "In Vitro Assessment of Dermal Absorption", KAO J, Dermal and Ocular Toxicology: Fundamentals and Methods, CRC PRESS, (1991), pages 272 - 273
Type:Non-patent literature
Publication information:   - WILEN, S.H. ET AL., TETRAHEDRON, (1977), vol. 33, page 2725
Type:Non-patent literature
Publication information:   - WILEN, S.H., Tables of Resolving Agents and Optical Resolutions, UNIV. OF NOTRE DAME PRESS, (1972), page 268
Type:Non-patent literature
Publication information:   - T. PHARMACEUTICAL SCIENCES, (1977), vol. 66, pages 1 - 19
Type:Non-patent literature
Publication information:   - BARRETT CW, "Skin penetration", J. SOC. COSMETIC CHEMISTS, (1969), vol. 20, pages 487 - 499
Type:Non-patent literature
Publication information:   - BLUME-PEYTAVI U ET AL., "A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia", JAM ACAD DERMATOL, (2012), vol. 66, doi:doi:10.1016/j.jaad.2011.05.026, pages 794 - 800, XP055372723
DOI: http://dx.doi.org/10.1016/j.jaad.2011.05.026
Type:Non-patent literature
Publication information:   - SHARIF ET AL., J. OCULAR PHARMACOL. THER., (2002), vol. 18, pages 313 - 324